IL6 and myeloid sarcoma: These cells areproven to be potentially effective in MS treatmentdue to their immunomodulatory properties(regulation and maintenance of Treg lymphocytefunction) (72) and paracrine effects (via bioactivegrowth factor secretion and IL-6 and TGF-βproduction) (73).